News Letter to Shareholders and Corporate Update Continue Reading Previous Sandoz announces exclusive deal to commercialize biosimilar ustekinumab, further reinforcing growing pipeline and immunology patient offeringNext Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD Related Stories News TransNusa Launches Maiden Bali-Phuket Flight for the Ultimate Island-Hopping Experience News The 43rd Hong Kong Watch & Clock Design Competition results announced News Universitas Brawijaya Forest operates thermal drone to strengthen fire mitigation News YDC 2026 unveils its winners in spectacular fashion News TMX Group Consolidated Trading Statistics – August 2026 News Pioneer AI Foundry Board Composition Changes
